Copyright
©The Author(s) 2025.
World J Stem Cells. Jul 26, 2025; 17(7): 108202
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.108202
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.108202
Table 2 Detailed information about the characteristics of mesenchymal stem cells that are used in studies that underwent meta-analysis, and the various methods by which mesenchymal stem cells are grafted
Ref. | Source of MSCs | Type of graft of MSCs | Type of grafting method of MSCs | Targeted tissue/organ |
Cai et al[12] | UC-MSCs and aBM-MNCs | Allogeneic | Intra-arterial infusion via supra-selective pancreatic artery cannulation | Pancreas |
Packham et al[13] | BM-MPCs | Allogeneic | IV infusion | Kidneys |
Carlsson et al[14] | BM-MSCs | Autologous | IV infusion | Pancreas |
Leão et al[15] | ASCs | Allogeneic | IV infusion | Systemic administration |
Skyler et al[16] | BM-MPCs | Allogeneic | IV infusion | Systemic administration |
Thakkar et al[17] | IS-AD-MSCs and BM-HSCs | Autologous | Infusion into the portal vein, thymic circulation, and subcutaneous tissue | Pancreas and subcutaneous tissue |
Zhao et al[18] | CB-SCs | Allogeneic | Stem cell educator therapy | Pancreas |
Re-infusion of educated lymphocytes into the patient’s circulation | ||||
Wu et al[19] | BM-MNCs | Autologous | Pancreatic intra-arterial infusion via the dorsal pancreatic artery | Pancreas |
Wu et al[20] | BM-MSCs | Autologous | Intra-arterial and intravenous infusion | Pancreas |
- Citation: Aringazina RA, Zare A, Mousavi SM, Abenova N, Mussin NM, Tamadon A. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. World J Stem Cells 2025; 17(7): 108202
- URL: https://www.wjgnet.com/1948-0210/full/v17/i7/108202.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i7.108202